1992
DOI: 10.1080/07391102.1992.10508632
|View full text |Cite
|
Sign up to set email alerts
|

Locating Binding Sites for the Carcinogen N-Acetoxy-N-Acetyl-2-Aminofluorene Using Restriction Enzyme Inhibition Assays

Abstract: Restriction enzyme inhibition studies have been employed to map the locations of high affinity binding sites of the carcinogen N-acetoxy-N-acetyl-2-aminofluorene (acetoxyAAF) on pBR322, phiX174 and SV40 DNAs. Bound carcinogen levels were kept low (less than 20 bound AAF moieties per DNA molecule) in order to observe only the binding to the high affinity sites. Inhibition of certain restriction enzymes was observed in a limited number of locations on these DNAs. Inhibition increased as bound AAF increased and t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
2
0

Year Published

2004
2004
2011
2011

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 21 publications
1
2
0
Order By: Relevance
“…The inhibition of Mbol activity on B-form BZ-III by actinomycin, ametantrone, and ethidium is expected and is similar to that observed previously with various restriction enzymes and DNA-binding molecules (Hardwick et al, 1984;Ushay et al, 1981; Barton & Paranawithana, 1986; Mallamaci et al, 1991). Inhibition by these agents of Mbol cleavage of BZ-III containing both B and Z conformations is also observed.…”
Section: Discussionsupporting
confidence: 86%
“…The inhibition of Mbol activity on B-form BZ-III by actinomycin, ametantrone, and ethidium is expected and is similar to that observed previously with various restriction enzymes and DNA-binding molecules (Hardwick et al, 1984;Ushay et al, 1981; Barton & Paranawithana, 1986; Mallamaci et al, 1991). Inhibition by these agents of Mbol cleavage of BZ-III containing both B and Z conformations is also observed.…”
Section: Discussionsupporting
confidence: 86%
“…To probe the plasmid DNA, we first needed to develop an appropriate assay. Our approach was based in part on the experiments of Winkle and Mallamaci, who utilized restriction enzyme mapping to detect binding of carcinogens to pBR322. , Here, our goal was to develop a nonradioactive assay involving the inhibition of restriction enzyme cleavage and to determine if such an assay could be used to probe whether specific sites on the DNA had undergone cross-linking. Figure illustrates that cross-linking of histone with linear pBR322 leads to a decreased mobility that can be mostly restored upon treatment with protease, as seen previously for supercoiled DNA, consistent with oxidative cross-linking.…”
Section: Discussionmentioning
confidence: 99%
“…Some carcinogens present an adduction selectivity for particular sequences, such as benzo[ a ]pyrene which generates more adducts at the central G of sequences 5′ CGG 3′ , 5′ TGG 3′ , 5′ TGT 3′ and 5′ CGT 3′ 23, 24. Similarly, N ‐acetoxy‐ N ‐acetyl‐2‐aminofluorene (AAAF) is fixed to specific sites of pBR322 plasmid,25, 26 and a metabolite of benzo[ c ]phenanthrene has been described to bind predominantly to the hot spot of the carcinogen (+)‐(7 R, 8 S, 9 S, 10 R )‐isomer of benzo[ a ]pyrene 7,8‐diol 9,10‐epoxide ((+)‐BaP DE‐2) in the Chinese hamster hprt gene 27. In order to obtain more precise information on the flanking bases effect on the adduct formation, Vouros and co‐workers have developed a pseudo‐combinatory method based on a partial digestion of modified DNA followed by a characterization of modified oligomers (mainly trimers) by liquid chromatography coupled to mass spectrometry (LC/MS) 28.…”
mentioning
confidence: 99%